April 4th, 2020
The CARES Act
New Guidance for Bioscience Startups The CARES Act was signed March 27th with the goal to inject liquidity into an American economy profoundl.....
February 26th, 2020
When the Going Gets Tough, the Tough … Call in the Experts
Ask any of BioEnterprise's Executives-in-Residence what makes starting a bioscience business so different from other startups, and you’ll likely hear .....
January 28th, 2020
Move Over Opioids, Neuromodulation Is What’s Next.
Cleveland has long been at the forefront of an industry gaining new traction as an effective and drug-free pain remedy: neuromodulation. Neuromodul.....
May 3rd, 2019
Check out Inc. Magazine’s recognition of Cleveland as a Surge City, thanks to our welcoming startup scene and thriving biomedical sector.
May 3rd, 2019
Matt McBride Joins BioEnterprise as VP of the Global Center for Health Innovation
May 26th, 2017
Opening the Door to Hospital Sales: “Strategic Keys to Success: Planning and Commercialization Strategies”
It is critically important to have a robust commercialization strategy in order to develop and sell a new medical device or diagnostic product to hospitals. In this session, experienced industry professionals and specialized consultants will discuss the critical elements that need to be addressed, including the importance of claims to support regulatory requirements and marketing and sales objectives.
December 15th, 2016
Opening the Door to Hospital Sales: “An Insider’s View of Segments, Stakeholders, and Protocols”